Virtual doppelgänger may help pick right patients for kidney nerve treatment

NCT ID NCT07462572

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study will test whether a personalized computer model, called a 'digital twin,' can predict which patients with high blood pressure will respond to a procedure called renal denervation. The study will enroll 60 people, including those with resistant hypertension, untreated hypertension starting medication, and those with a hormone condition called primary aldosteronism. Researchers will build each patient's digital twin from routine test results and see if it can accurately forecast blood pressure changes three months after treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

digital twin computer model

What this could lead to

If successful, this could help doctors personalize treatment decisions for high blood pressure, reducing unnecessary procedures and improving outcomes.

What could go wrong

This is a small pilot study (60 participants) that is not yet recruiting. The digital twin is a new tool and may not accurately predict responses in real-world settings.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

essential hypertension hyperaldosteronism hypertensive disorder primary aldosteronism resistant hypertension

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hypertension Unit - Georges Pompidou European Hospital

    Paris, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Pharmacology Unit - Georges Pompidou European Hospital

    Paris, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••